DoseMeRx Users
Southwest Leadership Forum
Thursday, March 3, 2022
12PM CT / 11AM MT
This free, virtual event is hosted by Dr. Tom Lodise, PharmD, PhD, a co-author of the 2020 vancomycin guidelines. You’ll hear leading DoseMeRx users present real-world case studies and have opportunity to participate in roundtable discussions.
Topics to be discussed include:
- How to develop a best practice protocol for Bayesian-guided vancomycin dosing
- Key strategies and tools for implementing Bayesian-AUC guided vancomycin monitoring within the electronic health record (EHR)
- How to approach and educate key stakeholders when implementing Bayesian dosing, including: IT, Physicians, Administrators, Nurses, and Laboratory
- Tracking the success of your Bayesian dosing program through data, analytics, and benchmarks
Your hosts
Tom Lodise, PharmD, PhD, Professor, Albany College of Pharmacy and Health Sciences
Dr. Lodise is a Professor at Albany College of Pharmacy and Health Sciences in Albany, New York. He received his Doctor of Pharmacy from Temple University School of Pharmacy and his Doctor of Philosophy in Epidemiology from the State University of New York School of Public Health. Integrating his dual interests in scholarship and patient care, Dr. Lodise’s overall research goal is to quantitatively enhance our current understanding of antimicrobial exposure-response relationships in patients with invasive bacterial infections. His research encompasses three interrelated domains: pharmacokinetics (PK)/pharmacodynamics (PD), epidemiology, and outcomes.
Kristi Kuper, PharmD, BCPS, FIDSA, Director of Clinical Pharmacy at DoseMeRx
Dr. Kuper is a Board Certified Pharmacotherapy Specialist who has spent the last 20 years in a variety of clinical pharmacy leadership roles working with more than 500 hospitals. She has contributed to over 40 publications and has experience co-leading national research projects on under-researched areas in antibiotic stewardship. She is a recognized expert in the use of clinical decision support to improve medication utilization in the acute care setting.